General

Praxeology: A holistic approach to human behaviour

In philosophy, praxeology or praxiology (/ˌpræksiˈɒlədʒi/; from Ancient Greek πρᾶξις (praxis) ‘deed, action’, and -λογία (-logia) ‘study of’) is the theory of human action, based on...

Albert Pike’s vision of three world wars (1871)

https://en.wikipedia.org/wiki/Albert_Pike “The First World War must be brought about in order to permit the Illuminati to overthrow the power of the Czars in Russia and...

Hail Hydra (Hydra vulgaris)

“As far as we can tell, it doesn’t age or die,” says Assistant Professor Celina Juliano, Department of Molecular and Cellular Biology. “You can...

Prof. Noam Chomsky on the State-Corporate Complex: A Threat to Freedom and Survival

Abuse of authority by the UN: Sexual exploitation and abuse of children covered up

In reviewing the UN’s response to the Allegations on the ground, the Panel finds that the head of HRJS and the SRSG of MINUSCA...

Humes’ is-ought problem

The is–ought problem, as articulated by the Scottish philosopher and historian David Hume, arises when one makes claims about what ought to be that...

Hormesis in toxicology

Hormesis is a characteristic of many biological processes, namely a biphasic or triphasic response to exposure to increasing amounts of a substance or condition....

Brain Science from Bench to Battlefield: The Realities – and Risks – of Neuroweapons | CGSR Seminar

Dr. James Giordano: https://clinicalbioethics.georgetown.edu/jgiordano/ Animated version: https://cognitive-liberty.online/the-matrix-agent-smith-and-dual-use-neuroscience/ James Giordano, PhD, MPhil, is Chief of the Neuroethics Studies Program, Scholar-in-Residence, leads the Sub-Program in Military...

Neuroweapons & neurohacking (dual-use neuroscience)

  Why Gene Editors Like CRISPR/Cas May Be a Game-Changer for Neuroweapons “This year marks the Eighth Review Conference (RevCon) of the Biological Toxins...

In vivo gene editing

“In vivo gene editing in post-mitotic neurons of the adult brain may be a useful strategy for treating neurological diseases. Here, we develop CRISPR–Cas9...